AxoGen(us:AXGN)
15.64
+5.32%
Updated on 2024-12-22
Open:14.66
Close:15.64
High:15.89
Low:14.54
Pre Close:14.85
Volume:1.10M
Amount:17.12M
Turnover:2.50%
Shares:44.01M
MarketCap:688.29M
About AxoGen Company
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Company Name: AxoGen
Company Address: 13631 Progress Boulevard,Suite 400
Employees: 428
Fiscar Year: 12-31
IPO Date: 2013-08-09
Website: http://www.axogeninc.com
CIK: 805928
View all SEC Filings
About
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
Address:13631 Progress Boulevard,Suite 400
Website:http://www.axogeninc.com
Market Movers